Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
171.15
-3.3 (-1.89%)
BSENSE

May 08

BSE+NSE Vol: 29.67 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
51.59
65.96
43.85
283.70
51.97
36.87
32.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
51.59
65.96
43.85
283.70
51.97
36.87
32.19
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
2.05
1.02
0.28
4.35
0.95
5.21
3.75
(Increase) / Decrease In Stocks
-55.45
-78.57
-4.97
26.62
-84.87
-79.59
8.03
Employee Cost
4.21
11.61
10.39
9.59
6.34
10.49
8.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
69.20
106.33
21.80
108.85
101.60
86.87
0.69
Selling and Distribution Expenses
18.67
12.14
4.93
86.70
11.23
2.57
3.15
Other Expenses
8.43
9.85
5.31
9.30
16.31
3.28
2.81
Total Expenditure (Excl Depreciation)
47.11
62.38
37.74
245.41
51.56
28.83
27.37
Operating Profit (PBDIT) excl Other Income
4.48
3.58
6.11
38.29
0.41
8.04
4.82
Other Income
2.38
1.74
1.93
1.76
3.86
0.48
0.08
Operating Profit (PBDIT)
6.86
5.32
8.04
40.05
4.27
8.52
4.90
Interest
4.59
4.54
3.66
3.20
1.37
3.90
2.98
Exceptional Items
1.26
2.69
2.06
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
3.53
3.47
6.44
36.85
2.90
4.62
1.92
Depreciation
1.03
0.98
0.99
0.98
1.34
0.83
0.83
Profit Before Tax
2.49
2.48
5.46
35.88
1.57
3.79
1.09
Tax
2.50
0.87
0.64
0.66
0.63
1.14
-0.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-0.01
1.60
4.82
35.22
0.94
2.65
1.11
Extraordinary Items
0.00
0.00
0.00
2.06
0.54
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-0.01
1.60
4.82
37.28
1.48
2.65
1.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-0.01
1.60
4.82
37.28
1.48
2.65
1.11
Equity Capital
19.00
19.00
19.00
19.00
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
-0.01
0.84
2.54
19.62
0.78
1.39
0.58
Diluted Earnings per share
-0.79
0.89
2.53
19.58
0.42
1.33
0.53
Operating Profit Margin (Excl OI)
8.68%
5.43%
13.93%
13.5%
0.79%
21.81%
14.97%
Gross Profit Margin
6.84%
5.26%
14.69%
12.99%
5.58%
12.53%
5.96%
PAT Margin
-0.02%
2.43%
10.99%
12.41%
1.81%
7.19%
3.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -0.73% vs 20.75% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -100.68% vs -43.51% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 992.68% vs -89.57% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 235.04% vs 28.04% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Nath Bio-Genes With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
51.59
0
51.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
51.59
0
51.59
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
2.05
0
2.05
(Increase) / Decrease In Stocks
-55.45
0
-55.45
Employee Cost
4.21
0
4.21
Power Cost
0.00
0
0.00
Manufacturing Expenses
69.20
0
69.20
Selling and Distribution Expenses
18.67
0
18.67
Other Expenses
8.43
0.00
8.43
Total Expenditure (Excl Depreciation)
47.11
0
47.11
Operating Profit (PBDIT) excl Other Income
4.48
0.00
4.48
Other Income
2.38
0
2.38
Operating Profit (PBDIT)
6.86
0
6.86
Interest
4.59
0
4.59
Exceptional Items
1.26
0
1.26
Gross Profit (PBDT)
3.53
0
3.53
Depreciation
1.03
0
1.03
Profit Before Tax
2.49
0
2.49
Tax
2.50
0
2.50
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-0.01
0
-0.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-0.01
0
-0.01
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.01
0
-0.01
Equity Capital
19.00
0
19.00
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
-0.01
0
-0.01
Diluted Earnings per share
-0.79
0
-0.79
Operating Profit Margin (Excl OI)
8.68%
0%
0.00
8.68%
Gross Profit Margin
6.84%
0%
0.00
6.84%
PAT Margin
-0.02%
0%
0.00
-0.02%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 51.59 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -21.79% vs 50.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -0.73% vs 20.75% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.01 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -100.63% vs -66.80% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -100.68% vs -43.51% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.48 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 25.14% vs -41.41% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 992.68% vs -89.57% in Mar 2025

Quarterly - Interest
Interest 4.59 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.10% vs 24.04% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 235.04% vs 28.04% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.68%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025